Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
QABClass II

Pacing System Analyzer

21 CFR 870.3605 / Cardiovascular

QAB is the FDA product code for Pacing System Analyzer, a class II device type, regulated under 21 CFR 870.3605. FDA's definition for this code reads: "The device is intended to supply an accurately calibrated, variable pacing pulse for measuring the patient’s pacing threshold and intracardiac R-wave potential. A pacing system analyzer (PSA) may be a single, dual, or triple chamber system and can simultaneously deliver pacing therapy while testing one or more...". As of , FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code
QAB
Device name
Pacing System Analyzer
FDA definition
The device is intended to supply an accurately calibrated, variable pacing pulse for measuring the patient’s pacing threshold and intracardiac R-wave potential. A pacing system analyzer (PSA) may be a single, dual, or triple chamber system and can simultaneously deliver pacing therapy while testing one or more implanted pacing leads.
Regulation
21 CFR 870.3605
Device class
Class II
Review panel
Cardiovascular
Submission type
510(k)
Implant
No
Life sustaining or supporting
Yes
GMP exempt
No
Third party review eligible
No
Ingested clearances
0
Ingested recalls
0

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code QAB.